Skip to content

Study on the effect of oral carbohydrates before painless colonoscopy on postoperative fatigue in patients

Study on the effect of oral carbohydrates before painless colonoscopy on postoperative fatigue in patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064071
Enrollment
Unknown
Registered
2022-09-25
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless colonoscopy

Interventions

test group:Instruct patients to fast after 20:00 the night before. Between two times of compound polyethylene glycol electrolyte powder solution (starting at 22:00), the patient took 400ml of Shuneng
control group:Instruct patients to fast after 20:00 the night before. Take 1 bag of Compound Polyethylene Glycol Electrolyte Powder, add it to 1000ml warm water, and drink it within 1 hour. 4:00 The s

Sponsors

Yichang First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients who are going to undergo painless colonoscopy, have no contraindications for diagnosis and treatment, and complete pre-anesthesia evaluation; (2) ASA I-II grade; (3) Patients aged 18-70 who have signed the informed consent for the trial.

Exclusion criteria

Exclusion criteria: (1) Those who are allergic to anesthetics; (2) ASA = grade III; (3) Patients with diabetes, gastroparesis, gastrointestinal stenosis or obstruction; (4) Patients with acute perforation of esophagus, stomach and duodenum or who need gastroscopic treatment; (5) Cardiovascular disease, such as severe heart disease such as severe arrhythmia, active myocardial infarction, severe heart failure, etc.; (6) Patients undergoing emergency endoscopy; (7) Refuse to sign the informed consent; (8) Those with poor compliance and unable to cooperate with diagnosis and treatment; (9) Those who have participated in clinical trials of other drugs within the past 4 weeks; (10) Patients with other conditions that the investigator considers unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Hemodynamics;Postoperative POSF score;

Secondary

MeasureTime frame
orthostatic pulse rate;blood sugar;electrolyte;bowel function recovery time;time of first bowel movement;

Countries

China

Contacts

Public ContactZhang Xiaoqing

Yichang First People's Hospital

276465976@qq.com15871635267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026